Disproquima launches vitamin K2 for heart and bone health

Published: 2-Jul-2021

Natural and sustainable (including vegan) product claims are the fastest-growing in Europe, the company says, and are set to rise further given consumer interest

Disproquima has introduced a vitamin K2 ingredient for cardiovascular and bone health, inspired by nature and soy bean sauce.

Natural and sustainable (including vegan) product claims are the fastest-growing in Europe, the company says, and are set to rise further given consumer interest.

The functional food ingredient for cardiovascular and bone health is produced by fermentation using a Bacillus subtilis natto strain isolated from Korean fermented soy-bean sauce. Its produced by clean supercritical extraction technology, the company says, and is non-GMO, preservatives and chemicals free and uses no synthetic process.

Matrix Gla protein (MGP), which is activated by vitamin K2, plays a key role in the inhibition of vascular tissue calcification. An adequate intake of vitamin K2 has been shown to positively influence the cardiovascular system.

Bone mineral density is directly related to the amount of MK-7 in the body, the company says. Bones grow and develop most intensively during childhood and adolescence, with up to 90% of peak bones mass acquired by 18.

By including enough MK-7 in their diet, Disproquima says, consumers will build healthy, strong bones, and age-related bone loss can be avoided.

You may also like